US Cancer Diagnostics Market Outlook: Innovations, Trends and Opportunities for Suppliers

Recommended by Dr. Michael White, Updated on May 4th, 2015
Rate this post

NEW YORK, July 2, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

US Cancer Diagnostics Market Outlook: Innovations, Trends and Opportunities for Suppliers

http://www.reportlinker.com/p01497959/US-Cancer-Diagnostics-Market-Outlook-Innovations-Trends-and-Opportunities-for-Suppliers.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=In_Vitro_Diagnostic

This report presents a comprehensive analysis of the US cancer diagnostics market, including:

Major issues pertaining to the US laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. Mortality statistics and scientific views on the etiology of major types of cancer, e.g., lung, colorectal, breast, prostatic, pancreatic, leukemia, lymphoma, gastrointestinal, bladder, liver, ovarian, testicular, oral, skin and others. Ten-year test volume and sales forecasts for 40 cancer diagnostic procedures performed in US hospitals, commercial laboratories, physician offices and cancer clinics. Placements and installed base of automated and semiautomated analyzers used for cancer testing. Current instrumentation technologies and feature comparison of leading analyzers. Sales and market shares of leading suppliers. Emerging diagnostic technologies and their potential market applications. Product development opportunities. Profiles of current and emerging suppliers, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies. Business opportunities and strategic recommendations for suppliers. Contains 620 pages and 103 tables

Table of Contents

Introduction Worldwide Market and Technology Overview A. Cancer Statistics and Etiology 1. Brest Cancer 2. Lung Cancer 3. Colon and Rectum Cancer 4. Prostate Cancer 5. Stomach Cancer 6. Leukemia 7. Lymphoma 8. Oral Cancer 9. Skin Cancer 10. Uterine Cancer 11. Ovarian Cancer 12. Bladder Cancer B. Major Current And Emerging Cancer Diagnostic Tests 1. Introduction 2. Tumor Marker Classification 3. ACTH 4. Alpha-Fetoprotein (AFP) 5. Beta-2 Microglobulin 6. CA 15-3/27.29 7. CA 19-9 8. CA-125 9. Calcitonin 10. Carcinoembrionic Antigen (CEA) 11. Estrogen and Progesterone Receptors 12. Ferritin 13. Gastrin 14. Human Chorionic Gonadotropin (HCG) 15. Insulin 16. NSE 17. Occult Blood 18. PAP Smear/HPV 19. Prostatic Acid Phosphatase (PAP) 20. Prostate-Specific Antigen (PSA) 21. Squamous Cell Carcinoma Antigen (SCC) 22. T and B Lymphocytes 23. TdT 24. Thyroglobulin 25. Tissue Polypeptide Antigen (TPA) 26. Biochemical Tumor Markers - ADA - B-Protein - PNP - 5'-Nucleotidase 27. Oncogenes - Abl/abl-bcr - AIB1 - BCL-2 - BRCA1 - CD44 - C-fos - C-myb - C-myc - CYP-17 - Erb-B - HPC1 - N-myc - P40 - P51 - P53 - PIK3CA - PTI-1 - Ras - Reg - Sis - Src 28. Polypeptide Growth Factors - Basic Fibroblast Growth Factor - Beta-TGF - Cachectin (TNT) - Calmodulin - ECFR - Nerve Growth Factor (NGF) - Epidermal Growth Factor (EGF) - Ornithine Decarboxylase - Transferrin - Transforming Growth Factor-Alpha 29. Ectopic Hormones 30. Colony Stimulating Factors 31. Lymphokines - Alpha-Interferon - B Cell Growth Factors - B Cell Growth Factor (BCGF) - Gamma-Interferon - Interleukin-1 (IL-1) - Macrophage Activating Factor 32. Immunohistochemical Stains 33. Emerging Tumor Markers - N-Acetylglucosamine - Actin - Alpha-Actin - Antineuronal Antibodies - 7B2 - B72.3 - Bax - BCD-F9 - BLCA-4 - Blood Group Antigens A,B,H - CA 50 - CA 72-4/TAG-72 - CA 195 - CA-242 - CA-549 - CAM 26 - CAR-3 - Cathepsin-D - Chromogranin A and B - Cluster 1 Antigen - Cluster-5/5A Antigen - CTA - CU18 - DR-70 - DU-PAN-2 - Endometrial Bleeding Associated Factor - Endostatin - Epithelial Membrane Antigen - Feulgen Hydrolysis - Fibronectin - FSH - (1->3)-L-fucosyltransferase - Gastrin-Releasing Peptide (GRP) - GDCFP-15 - Glucagon - Glycoamines - H23 - Her-2 - Human Carcinoma Antigen - HPA - HSP27 - Intermediate Filaments - Cytokeratins/CK18/Cyfra 21-1 - Desmin - Gliofibrillary Acid Protein - Neurofilaments - Vimentin - KA 93 - Kinases - KP16D3 - LAI - Leukocyte Common Antigen - Lewis Antigens - Lysophosphatidic Acid (LPA) - Ma 695/Ma 552 - MABDF3 - MAG - ME1 - Minactivin - MN/CA9 - MSA - Mucin Cancer Antigen (MCA) - Multiple Tumor Suppressor 1 - Myosin - NEA-130 - NMP22 - OA-519 - Opiod Peptides - P-glycoprotein - Pancreatic Oncofetal Antigen (POA) - Placental Lactogen - PR92 - Proliferative Index, Ki-67 - Px - RB Inactivation/Deletion - Ret - SCCL 175 - Selectin - Sialic Acid - Sialyl SSEA-1/SLX - SN10 - Somatostatin - TA-90 - TABA - Tachykinin - TAG 12 - TPS - Troponin - Tubulin - VCAM - VEGF - Villen C. Instrumentation Review And Market Needs 1. Abbott AxSYM 2. Abbott Architect c4000 3. Abbott Architect i2000 Series 4. Abbott Architect ci8200 System 5. Beckman Coulter UniCel Series 6. Beckman Coulter Access 7. Binding Site ESP600 8. bioMerieux Mini Vidas 9. Carolina Chemistries BioLis 24i 10. DiaSorin Liaison 11. Horiba ABX Pentra 400 12. Inverness DS2 13. J&J Vitros ECi/ECiQ 14. J&J Vitros 3600 15. J&J Vitros 5600 16. Olympus AU5400 17. Olympus AU3000i 18. Olympus AU2700 19. Roche Modular Analytics 20. Roche Cobas Integra 400 21. Roche Cobas Integra 400 Plus 22. Roche Elecsys 23. Roche Cobas c311 24. Siemens ADVIA Centaur 25. Siemens Dimension 26. Siemens Dimension RxL Max 27. Siemens Dimension Vista 500 28. Siemens Immulite 29. Siemens Stratus 30. Tosoh AIA-Series 31. Vital Diagnostics ATAC 8000 32. Vital Diagnostics Envoy 500 D. Current and Emerging Technologies 1. Monoclonal and Polyclonal Antibodies 2. Immunoassays a. Technological Principle b. Radioimmunoassay (RIA) c. Enzyme Immunoassays (EIA) - Overview - ELISA - Immunofiltration - Particle-Membrane Capture Immunoassay - Enzyme Amplification d. Fluorescent Immunoassays e. Luminescence - Chemiluminescence - Bioluminescence f. Latex Agglutination g. Immunoprecipitation H. Affinity Chromatographu e. Liposome Flow-Injection Immunoassay 3. Molecular Diagnostics a. Technology Overview b. Amplification Methods - PCR - DAP-PCR - Immuno-PCR - QC-PCR - CAR - DNA - HPA - LCR - NASBA - QBR - SDA - 3 SR, and others 4. Chromosome Analysis a. Chronic Myelogenous Leukemia (CML) b. Acute Myeloid Leukemia (AML) c. Acute Lymphoblastic Leukemia (ALL) d. Malignant Lymphomas Lymphoid Malignancies e. Chronic Lymphocytic Leukemia (CLL) f. Solid Cancers g. Chromosomal Translocation and Oncogenes 5. Artificial Intelligence 6. Flow Cytometry 7. Two Dimensional Gel Electrophoresis (2-DGE) 8. Biosensors 9. Competing/Complementing Technologies a. CT b. MRI c. NMR d. PET e. Photonics Spectroscopy E. Personal Testing U.K. A. Executive Summary B. Business Environment C. Market Structure D. Market Size, Growth and Major Suppliers Major Product Development Opportunities A. Reagent Kits and Test Systems/Panels B. Instrumentation C. Computers, Software and Automation D. Auxiliary Products Design Criteria for Decentralized Testing Products Alternative Market Penetration Strategies A. Internal Development B. Collaborative Arrangements C. University Contracts D. Distribution Strategies 1. Marketing Approaches 2. Product Complexity 3. Customer Preference 4. Established Suppliers 5. Emerging Suppliers 6. Major Types of Distributors 7. Market Segmentation Factor Potential Market Entry Barriers and Risks A. Market Maturity B. Cost Containment C. Competition D. Technological Edge and Limitations E. Patent Protection F. Regulatory Constraints G. Decentralized Testing Market Challenges Competitive Profiles - Abbott - AdnaGen - Applied Gene Technologies - Arca - Beckman Coulter/Danaher - Becton Dickinson - Biomedical Diagnostics - bioMerieux - Bio-Rad - Cepheid - Correlogic Systems - Dako - Decode - Diadexus - Diagnocure - Diasorin - Eiken Chemical - Enterix - Enzo Biochem - Epigenomics - Exact Sciences - Fujirebio - Gen-Probe - Guided Therapeutics - Hologic - Ipsogen - Kreatech - Kyowa Medex - Life Technologies - Mackay Life Sciences - Myriad Genetics - Nanogen Elitech - OncoLab - Otho-Clinical Diagnostics - Panacea Pharmaceuticals - Polartechnics - Polymedco - PreMD - Qiagen - Radient Pharmaceuticals - Roche - Scienion - Sequenom - Siemens Healthcare - Takara Bio - Targeted Diagnostics & Therapeutics - Tosoh - Veridex - Wako Pure Chemicals - Wallac/PE - Zila Appendixes Appendix I: Major Universities and Research Centers Developing Cancer Diagnostic Technology and Applications Appendix II: Assumed Currency Exchange Rates

List of Tables Tumor Marker Classification Major Companies Developing or Marketing ACTH Tests Major Companies Developing or Marketing AFP Tests Major Companies Developing or Marketing Beta-2 Microglobulin Tests Major Companies Developing or Marketing CA 15-3/27.29 Tests Major Companies Developing or Marketing CA 19-9 Tests Major Companies Developing or Marketing CA 125 Tests Major Companies Developing or Marketing Calcitonin Tests Major Companies Developing or Marketing CEA Tests Major Companies Developing or Marketing Estrogen Receptor Tests Major Companies Developing or Marketing Progesterone Receptor Tests Major Companies Developing or Marketing Ferritin Tests Major Companies Developing or Marketing Gastrin Tests Major Companies Developing or Marketing HCG Tests Major Companies Developing or Marketing Insulin Tests Major Companies Developing or Marketing NSE Tests Major Companies Developing or Marketing Occult Blood Tests Major Companies Developing or Marketing PAP Smear/HPV Tests Major Companies Developing or Marketing PAP Tests Major Companies Developing or Marketing PSA Tests Major Companies Developing or Marketing Lymphocyte Subclassification Tests Biochemical Markers Potential Applications In Cancer Diagnosis Oncogenes Potential Applications In Cancer Diagnosis Major Companies Developing or Marketing Oncogene Tests Growth Factors Potential Applications In Cancer Diagnosis Colony Stimulating Factors Potential Applications in Cancer Diagnosis Lymphokines Potential Applications In Cancer Diagnosis Immunohistochemical Stains Potential Applications in Cancer Diagnosis Executive Summary Table: U.K., Total Tumor Marker Test Volume and Sales Forecast by Market Segment U.K., Estimated Cancer Death Rates Per 100,000 Population U.K., Laboratories Performing Tumor Marker Tests by Market Segment U.K., Hospital Laboratories Performing Tumor Marker Tests by Bed Size U.K., Commercial/Private Laboratories Performing Tumor Marker Tests by Annual Test Volume U.K., Total Tumor Marker Testing Volume Forecast by Market Segment U.K., All Market Segments Major Tumor Marker Test Volume Forecast U.K., Hospital Laboratories Major Tumor Marker Test Volume Forecast by Test U.K., Commercial/Private Laboratories Major Tumor Marker Test Volume Forecast U.K., Total Tumor Marker Sales Forecast by Market Segment U.K., All Market Segments Major Tumor Marker Sales Forecast by Test U.K., Hospital Laboratories Major Tumor Marker Sales Forecast by Test U.K., Commercial/Private Laboratories Major Tumor Marker Sales Forecast by Test U.K., ACTH Test Volume and Diagnostics Sales Forecast by Market Segment U.K., AFP Test Volume and Diagnostics Sales Forecast by Market Segment U.K., Beta-2 Microglobulin Test Volume and Diagnostics Sales Forecast by Market Segment U.K., CA 15-3/27.29 Test Volume and Diagnostics Sales Forecast by Market Segment U.K., CA 19-9 Test Volume and Diagnostics Sales Forecast by Market Segment U.K., CA-125 Test Volume and Diagnostics Sales Forecast by Market Segment U.K., Calcitonin Test Volume and Diagnostics Sales Forecast by Market Segment U.K., CEA Test Volume and Diagnostics Sales Forecast by Market Segment U.K., Chromogranin Test Volume and Diagnostics Sales Forecast by Market Segment U.K., Colon-Specific Antigen Test Volume And Diagnostics Sales by Market Segment U.K., Cytokeratins Test Volume and Diagnostics Sales Forecast by Market Segment U.K., Estrogen Receptor Test Volume and Diagnostics Sales Forecast by Market Segment U.K., Ferritin Test Volume and Diagnostics Sales Forecast by Market Segment U.K., Gastrin Test Volume and Diagnostics Sales Forecast by Market Segment U.K., HCG Test Volume and Diagnostics Sales Forecast by Market Segment U.K., Insulin Test Volume and Diagnostics Sales Forecast by Market Segment U.K., Lymphocyte Subtyping Test Volume and Diagnostics Sales Forecast by Market Segment U.K., NSE Test Volume and Diagnostics Sales Forecast by Market Segment U.K., Occult Blood Test Volume and Diagnostics Sales Forecast by Market Segment U.K., Oncogenes Test Volume and Diagnostics Sales Forecast by Market Segment U.K., Pancreatic Oncofetal Antigen Test Volume and Diagnostics Sales Forecast by Market Segment U.K., PAP Smear Test Volume and Diagnostics Sales Forecast by Market Segment U.K., Parathyroid Hormone Test Volume and Diagnostics Sales Forecast by Market Segment U.K., Progesterone Receptor Test Volume and Diagnostics Sales Forecast by Market Segment U.K., PAP Test Volume and Diagnostics Sales Forecast by Market Segment U.K., PSA Test Volume and Diagnostics Sales Forecast by Market Segment U.K., S-100 Protein Test Volume and Diagnostics Sales Forecast by Market Segment U.K., Serotonin Test Volume and Diagnostics Sales Forecast by Market Segment U.K., Sialic Acid Test Volume and Diagnostics Sales Forecast by Market Segment U.K., Squamous Cell Carcinoma Antigen Test Volume and Diagnostics Sales Forecast by Market Segment U.K., TDT Test Volume and Diagnostics Sales Forecast by Market Segment U.K., Thymidine Kinase Test Volume and Diagnostics Sales Forecast by Market Segment U.K., Thyroglobulin Test Volume and Diagnostics Sales Forecast by Market Segment U.K., TPA Test Volume and Diagnostics Sales Forecast by Market Segment U.K., Total Tumor Marker Sales and Market Shares Forecast U.K., CEA Testing Market Diagnostics Sales by Major Supplier U.K., PSA Testing Market Diagnostics Sales by Major Supplier

To order this report: In_Vitro_Diagnostic Industry: US Cancer Diagnostics Market Outlook: Innovations, Trends and Opportunities for Suppliers

Contact Clare: clare@reportlinker.com US:(339) 368 6001 Intl:+1 339 368 6001

Read more here:

US Cancer Diagnostics Market Outlook: Innovations, Trends and Opportunities for Suppliers

Related Post

Word Count: 2042

Comments are closed.


signs levels specialist low testosterone symptoms and of
what are normal levels by testosterone chart age

hormone replacement